Literature DB >> 31504302

Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States.

Tatyana Kushner1, Zhen Chen2, Stacy Tressler3, Harvey Kaufman2, Judith Feinberg4, Norah A Terrault5.   

Abstract

BACKGROUND: The current opioid injection drug use epidemic has been associated with an increase in hepatitis C virus infections among women of childbearing age in the United States, but changes in hepatitis B virus (HBV) infections have not been studied.
METHODS: A retrospective analysis of HBV statuses among women of childbearing age nationally and by state was conducted, utilizing the Quest Diagnostics database. Rates of HBV in women born before and after the implementation of universal HBV vaccination recommendations were determined.
RESULTS: We identified 8 871 965 women tested for HBV from 2011-2017. Nationally, the annual rate of acute HBV infections was stable, but rates increased in Kentucky, Alabama, and Indiana (P < .03). The national prevalence of new, chronic HBV diagnoses decreased significantly, from 0.83% in 2011 to 0.19% in 2017 (P < .0001), but increased in Mississippi, Kentucky, and West Virginia (P ≤ .05). A declining prevalence of HBV seroprotection was evident over time, especially within the birth-dose cohort (which dropped from 48.5% to 38.5%; P < .0001).
CONCLUSIONS: National rates of newly diagnosed acute and chronic HBV infections declined or were stable overall, but increased significantly in specific Appalachian states. The HBV vaccine is effective in decreasing infections, but seroprotection wanes over time. These trends in new infections may be related to increased injection drug use and highlight potential gaps in HBV vaccine protection.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  hepatitis B exposure; hepatitis B vaccination; hepatitis B virus; reproductive age; testing

Year:  2020        PMID: 31504302      PMCID: PMC7384310          DOI: 10.1093/cid/ciz841

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

Review 1.  Immunoglobulin class M anti-hepatitis B core antigen for serodiagnosis of acute hepatitis: pitfalls and recommendations.

Authors:  Chia-Ming Chu
Journal:  J Gastroenterol Hepatol       Date:  2006-05       Impact factor: 4.029

2.  Update: recommendations to prevent hepatitis B virus transmission--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-01-22       Impact factor: 17.586

3.  Duration of protection after infant hepatitis B vaccination series.

Authors:  Amy B Middleman; Carol J Baker; Claudia A Kozinetz; Saleem Kamili; Chi Nguyen; Dale J Hu; Philip R Spradling
Journal:  Pediatrics       Date:  2014-05-19       Impact factor: 7.124

4.  Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage.

Authors:  S Hustache; L Moyroud; L Goirand; O Epaulard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-11       Impact factor: 3.267

5.  Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States.

Authors:  H S Kim; L Rotundo; J D Yang; D Kim; N Kothari; M Feurdean; C Ruhl; A Unalp-Arida
Journal:  J Viral Hepat       Date:  2017-07-03       Impact factor: 3.728

6.  Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States and Kentucky, 2011-2014.

Authors:  Alaya Koneru; Noele Nelson; Susan Hariri; Lauren Canary; Kathy J Sanders; Justine F Maxwell; Xiaohua Huang; John A D Leake; John W Ward; Claudia Vellozzi
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-07-22       Impact factor: 17.586

7.  Hepatitis B Vaccination and Screening Among Foreign-born Women of Reproductive Age in the United States: 2013-2015.

Authors:  Greta A Kilmer; Laurie K Barker; Kathleen N Ly; Ruth B Jiles
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

8.  Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014.

Authors:  Kathleen N Ly; Ruth B Jiles; Eyasu H Teshale; Monique A Foster; Rick L Pesano; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2017-05-09       Impact factor: 25.391

9.  The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study.

Authors:  Ashley E Thompson; Yvonne Anisimowicz; Baukje Miedema; William Hogg; Walter P Wodchis; Kris Aubrey-Bassler
Journal:  BMC Fam Pract       Date:  2016-03-31       Impact factor: 2.497

10.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12
View more
  4 in total

1.  Age-specific seroprotection after Hepatitis B virus vaccination among Korean American pediatric population in Queens, New York.

Authors:  Esther Min; Jae Min; Roger Kim
Journal:  Hum Vaccin Immunother       Date:  2022-04-04       Impact factor: 4.526

2.  Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia.

Authors:  Stacy Tressler; Christa Lilly; Diane Gross; Thomas Hulsey; Judith Feinberg
Journal:  Am J Prev Med       Date:  2020-10-01       Impact factor: 5.043

3.  Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy.

Authors:  H Nina Kim
Journal:  Curr Hepatol Rep       Date:  2020-09-16

4.  Hepatitis C is associated with more adverse pregnancy outcomes than hepatitis B: A 7-year national inpatient sample study.

Authors:  Bing Chen; Yichen Wang; Marcia Lange; Tatyana Kushner
Journal:  Hepatol Commun       Date:  2022-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.